Affymetrix, Inc. (Nasdaq:AFFX), today reported that based on preliminary financial data, the Company expects total revenue for the third quarter of 2008 to be approximately $75 million. Global sales fell below expectations for the quarter driven by increased competition for academic research funding and continued softness in industrial spending. “We are disappointed with our results […]
Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company’s new 2.1 million-probe HD2 platform. Roche NimbleGen’s HD2 array platform greatly enhances the capability and resolution of CGH whole-genome analysis by providing a single array […]
Agilent Technologies Inc. (NYSE:A) today announced that the Turku Centre for Biotechnology of University of Turku and Abo Akademi University has achieved Certified Service Provider status for Agilent gene expression microarrays. The Centre achieved Agilent-certified status after completing training and passing a rigorous series of assessments that include: — demonstrating proficiency in analyzing Agilent’s 60-mer […]
Scripps Translational Science Institute, Navigenics, Affymetrix and Microsoft team on groundbreaking health study SAN DIEGO, Oct. 9 — A consortium of health care, technology and research leaders have joined forces in a first-of-its-kind research study to assess the behavioral impact of personal genetic testing on people who choose to receive such screenings to identify their […]
Arrayit and BioSystems International to Produce New Approach for Identifying Diseases SUNNYVALE, CA–Oct 7, 2008 — Integrated Media Holdings, Inc. (OTC BB:IMHI.OB – News) announced today that its wholly owned subsidiary, TeleChem International, Inc. doing business as Arrayit Company, has entered into an exclusive agreement with BioSystems International SAS for the supply and license rights […]
Affymetrix Inc., (Nasdaq:AFFX) today announced that one of South Africa’s largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, […]
MADISON, Wis–Researchers from France investigating DNA copy number changes associated with genetic disorders have reported the development and validation of a Roche NimbleGen CGH multiplex, microarray-based research method for detecting genomic deletions and duplications at high-resolution. The findings, published in the August 5 issue of the journal Human Mutation (1), identified highly precise, exon-level variants […]
ROCKVILLE, MD, October 6, 2008 – Ariadne today announced that World Fusion has become Ariadne’s exclusive distributor in Japan, and will serve as support center for its patent-pending MedScan® technology and Pathway Studio® product line. Powered by MedScan technology, Pathway Studio enables scientists to control vast amounts of publicly available information and supplements all stages […]
Custom Array Developed by Lawrence Berkeley National Laboratory is Recognized for Its Contribution to Air Quality Testing SANTA CLARA, Calif.–Affymetrix Inc. (Nasdaq:AFFX) announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal Technology Innovation Awards. The PhyloChip helps researchers identify […]
Affymetrix Inc. (Nasdaq:AFFX) and Medical Prognosis Institute A/S (MPI), a leading cancer diagnostic development company based in Denmark, today announced that they have signed a Powered by Affymetrix(TM) (PbA) agreement. With this agreement, MPI gains non-exclusive access to Affymetrix microarray technology to develop and commercialize drug sensitivity prediction and prognostic products for patients with cancer. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
